Stay updated on Dapagliflozin in Respiratory Failure Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in Respiratory Failure Clinical Trial page.

Latest updates to the Dapagliflozin in Respiratory Failure Clinical Trial page
- ChecktodayChange DetectedThe location label in New Delhi was updated from Saket to Sāket (with diacritic), and the page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check7 days agoChange DetectedLocation name corrected from Sāket to Saket, New Delhi, India, 110017, and the page revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check14 days agoChange DetectedSaket, New Delhi, India, 110017 was updated to Sāket, New Delhi, India, 110017 in the Locations section (non-accented entry removed).SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedAdded Revision: v3.4.2 and removed Notice about government funding lapse and Revision: v3.4.1; these are administrative changes to the page version and notices rather than content affecting the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check43 days agoChange DetectedLocation entry Saket, New Delhi, India, 110017 was added and the diacritic variant Sāket was removed, with the revision updated to v3.4.1. A government funding/status notice regarding NIH operations was added.SummaryDifference0.3%

- Check50 days agoChange DetectedShow glossary; add metadata entries like 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Older labels such as 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' were renamed or removed.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin in Respiratory Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Respiratory Failure Clinical Trial page.